A Trial of SHR-7782 for Treatment of Advanced Malignant Tumors

Clinical trial NCT07123129 · RECRUITING

Trial details

NCT number: NCT07123129
Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Malignancy

Start date: 2025-08-28
Primary completion: 2026-12-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.